Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.56 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | GABRR1 | P24046 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | CACNA2D1 | P54289 | 2/20 | 0.42 |
| ▸ | CACNB3 | P54284 | 1/20 | 0.42 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.42 |
| ▸ | PGR | P06401 | 1/20 | 0.42 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.42 |
| ▸ | HTR2B | P41595 | 1/20 | 0.42 |
| ▸ | CACNA2D2 | Q9NY47 | 1/20 | 0.42 |
| ▸ | GPR84 | Q9NQS5 | 4/20 | 0.41 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| (R)-3-Hydroxybutanoate SCHEMBL60959 | 1.00 | — | — | |
| (R)-3-Hydroxybutanoate SCHEMBL336331 | 1.00 | — | — | |
| (R)-3-Hydroxybutanoate SCHEMBL1533862 | 1.00 | SLC22A6 (0.56) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL28197574 | 1.00 | SLC22A6 (0.56) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| (R)-3-Hydroxybutanoate SCHEMBL29903959 | 1.00 | — | — | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL2731 | 1.00 | — | — | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL1881926 | 1.00 | SLC22A6 (0.56) | SLC22A6SMN1; SMN2MAPTGABRR1LMNA | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL2749471 | 0.97 | — | — | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL2342260 | 0.97 | — | — | |
| 3-Hydroxybutyric Acid, (+/-)- SCHEMBL9170835 | 0.97 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11950616-B2 | Non-vasoconstricting energy-promoting compositions containing ketone bodies | AXCESS GLOBAL SCIENCES, LLC (US) | 2024-04-09 | — | — | US | claimed |
| US-20230287435-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | AGAIN BIO APS (DK) | 2023-09-14 | — | — | US | claimed |
| CN-118604356-A | Noninvasive diagnosis biomarker combination for prostate cancer risk stratification and application thereof | 温州医科大学 | 2024-09-06 | — | — | CN | disclosed |
| US-11845861-B2 | Resin composition and molded article thereof | EASTMAN CHEMICAL COMPANY (US) | 2023-12-19 | — | — | US | disclosed |
| EP-3956286-B1 | METHOD FOR PRODUCING POLYOL-BASED ESTERS, IN PARTICULAR POLYGLYCEROL ESTERS, FROM HYDROXY CARBOXYLIC ACIDS | KETOLIPIX THERAPEUTICS GMBH (DE) | 2023-12-13 | — | — | EP | disclosed |
| US-11834567-B2 | Resin composition and molded article thereof | EASTMAN CHEMICAL COMPANY (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230287435-A1 | MICROORGANISMS AND METHODS FOR REDUCING BY-PRODUCTS | AGAIN BIO APS (DK) | 2023-09-14 | — | — | US | disclosed |
| CN-110872392-B | Resin composition and resin molded article | 伊士曼化工公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-111836852-B | Resin composition and resin molded article thereof | 伊士曼化工公司 | 2023-02-03 | — | — | CN | disclosed |
| CN-110872397-B | Resin composition and resin molded article | 伊士曼化工公司 | 2022-09-27 | — | — | CN | disclosed |
| CN-109553808-B | Resin composition and resin molded article thereof | 伊士曼化工公司 | 2022-09-13 | — | — | CN | disclosed |
| CN-107709542-A | The production of 3 hydroxybutyric acids | 赢创德固赛有限公司 | 2018-02-16 | — | — | CN | disclosed |
| CN-107495380-A | It is a kind of based on liter meal replacing food of ketone concept and application thereof | 迈德同信（武汉）科技股份有限公司 | 2017-12-22 | — | — | CN | disclosed |
| EP-2319508-A1 | Use of medium chain triglycerides for the treatment and prevention of Alzheimer's disease and other diseases resulting from reduced neuronal metabolism | Accera, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| CN-102007202-A | Applications of hydroxy fattyacid derivatives as fuels and fuel additives | UNIV SHANTOU | 2011-04-06 | — | — | CN | disclosed |
| EP-2143434-A1 | COMPOSITION FOR PROMOTING KETONE COMPOUND FORMATION | Earthus, Inc. (JP) | 2010-01-13 | — | — | EP | disclosed |
| CN-101489543-A | 3-hydroxy fatty acids and derivatives thereof for improving learning and/or memory in a subject | UNIV SHANTOU (CN) | 2009-07-22 | — | — | CN | disclosed |
| CN-1083112-A | A kind of method for determining bacteria and equipment | HE LIN (CN) | 1994-03-02 | — | — | CN | disclosed |
| US-4374925-A | PROTEIN BINDING ASSAYS | SYVA COMPANY (US) | 1983-02-22 | — | — | US | disclosed |
| US-4275149-A | IMMUNOASSAY | SYVA COMPANY (US) | 1981-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11950616-B2 | Non-vasoconstricting energy-promoting compositions containing ketone bodies | GPR119, CPT1B, CYP11B1 | SLC22A6 1048/4885SMN1; SMN2 729/4885MAPT 1616/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.